News

Penserra Capital Management significantly reduced its stake in Vertex Pharmaceuticals, dropping 81% of its shares in the ...
Formulas for the static and dynamic potentials due to linearly varying source distributions defined on a planar triangle are presented. The general linear variation of the source is represented in ...
Vertex expects to transition Trikafta patients to Alyftrek and build a multibillion-dollar pain management business, starting with this initial approval of Journavx for moderate-to-severe acute pain.
Vertex Pharmaceuticals has spent decades in the incredibly challenging field of pain research. After much trial and error, the Boston-based biotechnology company finally found a drug it believed ...
Prosper Junior Bakiny has positions in Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.
Vertex Pharmaceuticals VRTX initiated the late-stage portion of the phase II/III AMPLITUDE study evaluating inaxaplin (VX-147) in APOL1-mediated kidney disease (AMKD), a genetic disorder affecting ...
Collection of Signed Distance Functions in the form of Godot Visual Shader Language nodes. SDFs are shape-defining functions. You give them a point in n-dimensional space, and they tell you it's ...
Vertex Pharmaceuticals is the global leader in cystic fibrosis treatment and now is expanding into other areas that could bring in billion-dollar revenue.
Spread the loveA quadratic function is a polynomial equation of degree two which typically takes the form of y = ax^2 + bx + c, where a, b, and c are constants. The vertex of a quadratic function is ...
Say no to textures, yes to vertex colors! Vertex Color has 2 repositories available. Follow their code on GitHub.
Vertex also recently began a phase 2 trial in another form of neuropathic pain, known as painful lumbosacral radiculopathy (LSR), which has no FDA-approved drugs.
Vertex builds case for non-opioid pain drug ahead of key study readouts The closely watched medicine showed promise treating a form of chronic nerve pain, with the results suggesting comparable ...